Clinical Efficacy and Safety of Yangxin Shengmai Granules Combined with Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Refractory Heart Failure

GE Liying; CHEN Ailian; HU Jingguang

doi:10.12102/j.issn.1672-1349.2020.18.023

Home>Articles>Clinical Efficacy and Safety of Yangxin Shengmai Granules Combined with Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Refractory Heart Failure

DOI: 10.12102/j.issn.1672-1349.2020.18.023

Clinical Efficacy and Safety of Yangxin Shengmai Granules Combined with Recombinant Human Brain Natriuretic Peptide in the Treatment of Patients with Refractory Heart Failure

GE Liying

CHEN Ailian

HU Jingguang

Machine-generated Keywords：

Publication Date：2020-09-16

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 3035-3038 )

Chinese Journal of Integrative Medicine on Cardio/Cerebrovascular Disease

ISTIC

ISSN：1672-1349

Year, Vol.(Issue)：2020,18(18)